Who Can Participate?
Age Range
18-110
Looking for Healthy Participants
No
What is Involved?
Locations
Duke University Hospital
Visit Timing
Weekdays
Compensation
No
Spanish Materials Available
No
Study Details
Full Title
[20240031] A Phase 1/1b Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of AMG 410 Alone and in Combination with other agents in Participants with KRAS Altered Advanced or Metastatic Solid Tumors
Principal Investigator
John
Strickler
Protocol Number
PRO00118236
NCT ID
NCT07094113
Phase
I
Enrollment Status
Open to Enrollment